Machine learning-based tumor-infiltrating immune cell-associated lncRNAs for predicting prognosis and immunotherapy response in patients with glioblastoma
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Machine learning-based tumor-infiltrating immune cell-associated lncRNAs for predicting prognosis and immunotherapy response in patients with glioblastoma
Authors
Keywords
-
Journal
BRIEFINGS IN BIOINFORMATICS
Volume -, Issue -, Pages -
Publisher
Oxford University Press (OUP)
Online
2022-09-23
DOI
10.1093/bib/bbac386
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Glioma targeted therapy: insight into future of molecular approaches
- (2022) Keyang Yang et al. Molecular Cancer
- Neoadjuvant Chemoradiotherapy Combined with Atezolizumab for Resectable Esophageal Adenocarcinoma: A Single Arm Phase II Feasibility Trial (PERFECT)
- (2021) Tom van den Ende et al. CLINICAL CANCER RESEARCH
- Conserved pan-cancer microenvironment subtypes predict response to immunotherapy
- (2021) Alexander Bagaev et al. CANCER CELL
- Regulatory mechanisms of immune checkpoints PD-L1 and CTLA-4 in cancer
- (2021) Hao Zhang et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- The role of lncRNAs and circRNAs in the PD-1/PD-L1 pathway in cancer immunotherapy
- (2021) Wenxiao Jiang et al. Molecular Cancer
- Novel Immune Infiltrating Cell Signature Based on Cell Pair Algorithm Is a Prognostic Marker in Cancer
- (2021) Hao Zhang et al. Frontiers in Immunology
- Immune Infiltrating Cells-Derived Risk Signature Based on Large-scale Analysis Defines Immune Landscape and Predicts Immunotherapy Responses in Glioma Tumor Microenvironment
- (2021) Nan Zhang et al. Frontiers in Immunology
- Promoting Prognostic Model Application: A Review Based on Gliomas
- (2021) Xisong Liang et al. Journal of Oncology
- Intratumor heterogeneity: the hidden barrier to immunotherapy against MSI tumors from the perspective of IFN-γ signaling and tumor-infiltrating lymphocytes
- (2021) Wantao Wu et al. Journal of Hematology & Oncology
- Identification and validation of immune-related lncRNA prognostic signature for breast cancer
- (2020) Yong Shen et al. GENOMICS
- Identification of tumor immune infiltration-associated lncRNAs for improving prognosis and immunotherapy response of patients with non-small cell lung cancer
- (2020) Jie Sun et al. Journal for ImmunoTherapy of Cancer
- Computational recognition of lncRNA signature of tumor-infiltrating B lymphocytes with potential implications in prognosis and immunotherapy of bladder cancer
- (2020) Meng Zhou et al. BRIEFINGS IN BIOINFORMATICS
- LncRNAs as tumor cell intrinsic factors that affect cancer immunotherapy
- (2020) Sergey D. Egranov et al. RNA Biology
- Regression shrinkage methods for clinical prediction models do not guarantee improved performance: Simulation study
- (2020) Ben Van Calster et al. STATISTICAL METHODS IN MEDICAL RESEARCH
- Clinical characterization, genetic profiling, and immune infiltration of TOX in diffuse gliomas
- (2020) Hao Zhang et al. Journal of Translational Medicine
- A novel scoring method based on RNA‐Seq immunograms describing individual cancer‐immunity interactions
- (2020) Yukari Kobayashi et al. CANCER SCIENCE
- Immune-related lncRNAs as predictors of survival in breast cancer: a prognostic signature
- (2020) Wei Ma et al. Journal of Translational Medicine
- EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood
- (2020) Michael Weller et al. Nature Reviews Clinical Oncology
- Immune and genomic correlates of response to anti-PD-1 immunotherapy in glioblastoma
- (2019) Junfei Zhao et al. NATURE MEDICINE
- Brain Tumor Microenvironment and Host State: Implications for Immunotherapy
- (2019) William Tomaszewski et al. CLINICAL CANCER RESEARCH
- Mechanisms of immunotherapy resistance: lessons from glioblastoma
- (2019) Christopher M. Jackson et al. NATURE IMMUNOLOGY
- LncRNA SATB2-AS1 inhibits tumor metastasis and affects the tumor immune cell microenvironment in colorectal cancer by regulating SATB2
- (2019) Mu Xu et al. Molecular Cancer
- Identifying Cancer Driver lncRNAs Bridged by Functional Effectors through Integrating Multi-omics Data in Human Cancers
- (2019) Yong Zhang et al. Molecular Therapy-Nucleic Acids
- Overexpression of BLM promotes DNA damage and increased sensitivity to platinum salts in triple-negative breast and serous ovarian cancers
- (2018) N J Birkbak et al. ANNALS OF ONCOLOGY
- The Immune Landscape of Cancer
- (2018) Vésteinn Thorsson et al. IMMUNITY
- TIP: A web server for resolving tumor immunophenotype profiling
- (2018) Liwen Xu et al. CANCER RESEARCH
- Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response
- (2018) Peng Jiang et al. NATURE MEDICINE
- Long noncoding RNA s as regulators of cancer immunity
- (2018) Nerina Denaro et al. Molecular Oncology
- Pan-cancer analysis of transcriptional metabolic dysregulation using The Cancer Genome Atlas
- (2018) S. R. Rosario et al. Nature Communications
- IFN-γ–related mRNA profile predicts clinical response to PD-1 blockade
- (2017) Mark Ayers et al. JOURNAL OF CLINICAL INVESTIGATION
- Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trial
- (2017) Michael Weller et al. LANCET ONCOLOGY
- LncRNA-mediated regulation of cell signaling in cancer
- (2017) W-X Peng et al. ONCOGENE
- Integrated molecular analysis of tumor biopsies on sequential CTLA-4 and PD-1 blockade reveals markers of response and resistance
- (2017) Whijae Roh et al. Science Translational Medicine
- Pan-cancer Immunogenomic Analyses Reveal Genotype-Immunophenotype Relationships and Predictors of Response to Checkpoint Blockade
- (2017) Pornpimol Charoentong et al. Cell Reports
- Long Noncoding RNAs in Cancer Pathways
- (2016) Adam M. Schmitt et al. CANCER CELL
- Emerging role of long noncoding RNAs as regulators of innate immune cell development and inflammatory gene expression
- (2016) Roland Elling et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Explaining Support Vector Machines: A Color Based Nomogram
- (2016) Vanya Van Belle et al. PLoS One
- Glioblastoma: pathology, molecular mechanisms and markers
- (2015) Kenneth Aldape et al. ACTA NEUROPATHOLOGICA
- Integrative random forest for gene regulatory network inference
- (2015) Francesca Petralia et al. BIOINFORMATICS
- Noncoding RNA and its associated proteins as regulatory elements of the immune system
- (2014) Martin Turner et al. NATURE IMMUNOLOGY
- Oncology Meets Immunology: The Cancer-Immunity Cycle
- (2013) Daniel S. Chen et al. IMMUNITY
- An insight into classification with imbalanced data: Empirical results and current trends on using data intrinsic characteristics
- (2013) Victoria López et al. INFORMATION SCIENCES
- Predictive Gene Signature in MAGE-A3 Antigen-Specific Cancer Immunotherapy
- (2013) Fernando Ulloa-Montoya et al. JOURNAL OF CLINICAL ONCOLOGY
- Inferring tumour purity and stromal and immune cell admixture from expression data
- (2013) Kosuke Yoshihara et al. Nature Communications
- L 1 penalized continuation ratio models for ordinal response prediction using high-dimensional datasets
- (2012) K. J. Archer et al. STATISTICS IN MEDICINE
- Integrated Genomic Analysis Identifies Clinically Relevant Subtypes of Glioblastoma Characterized by Abnormalities in PDGFRA, IDH1, EGFR, and NF1
- (2010) Roel G.W. Verhaak et al. CANCER CELL
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started